Hamilton Lane (NASDAQ:HLNE) Stock Rating Lowered by Oppenheimer

Hamilton Lane (NASDAQ:HLNE) was downgraded by equities researchers at Oppenheimer from an “outperform” rating to a “market perform” rating in a research report issued on Thursday,Finviz reports.

A number of other research analysts also recently issued reports on the stock. JPMorgan Chase & Co. decreased their target price on shares of Hamilton Lane from $176.00 to $167.00 and set a “neutral” rating for the company in a research report on Tuesday, April 29th. Morgan Stanley lowered their target price on shares of Hamilton Lane from $190.00 to $157.00 and set an “equal weight” rating on the stock in a research note on Monday, April 14th. Wells Fargo & Company cut their price target on Hamilton Lane from $152.00 to $147.00 and set an “equal weight” rating for the company in a research note on Tuesday, April 8th. Finally, Keefe, Bruyette & Woods upped their price objective on shares of Hamilton Lane from $158.00 to $168.00 and gave the stock a “market perform” rating in a research report on Wednesday, February 5th. One analyst has rated the stock with a sell rating and six have issued a hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $164.14.

Hamilton Lane Stock Performance

HLNE stock opened at $174.82 on Thursday. The firm has a 50-day simple moving average of $147.94 and a two-hundred day simple moving average of $160.04. The firm has a market cap of $9.69 billion, a price-to-earnings ratio of 32.25 and a beta of 1.31. The company has a debt-to-equity ratio of 0.34, a quick ratio of 4.19 and a current ratio of 4.19. Hamilton Lane has a one year low of $114.85 and a one year high of $203.72.

Institutional Investors Weigh In On Hamilton Lane

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Kayne Anderson Rudnick Investment Management LLC acquired a new stake in shares of Hamilton Lane during the first quarter worth about $432,772,000. Price T Rowe Associates Inc. MD increased its position in Hamilton Lane by 229.7% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 1,292,266 shares of the company’s stock worth $191,321,000 after buying an additional 900,283 shares in the last quarter. Vanguard Group Inc. lifted its position in shares of Hamilton Lane by 28.4% in the fourth quarter. Vanguard Group Inc. now owns 3,901,933 shares of the company’s stock valued at $577,681,000 after acquiring an additional 863,326 shares in the last quarter. Champlain Investment Partners LLC purchased a new stake in shares of Hamilton Lane in the first quarter valued at $112,887,000. Finally, T. Rowe Price Investment Management Inc. increased its position in Hamilton Lane by 63.4% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 1,275,000 shares of the company’s stock worth $189,555,000 after purchasing an additional 494,637 shares in the last quarter. 97.40% of the stock is owned by hedge funds and other institutional investors.

About Hamilton Lane

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.